Zimbabwe: Parirenyatwa Accounts for 'Missing' U.S.$3,5 Million
[The Herald] THE introduction of the interbank exchange rate eroded US$3,5 million that was released by Government for the purchase of critical heart equipment for Parirenyatwa Group of Hospital's Catheterisation Laboratory, resulting in the hospital's failure to buy the equipment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 17, 2020 Category: African Health Source Type: news

Zimbabwe: Hospital Clears Air On 'Missing' U.S.$3,5 Million
[The Herald] THE introduction of the interbank exchange rate eroded the US$3,5 million that was released by Government for the purchase of critical heart equipment for Parirenyatwa Group of Hospitals' Catheterisation Laboratory, before the hospital could buy the equipment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 13, 2020 Category: African Health Source Type: news

Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization
The risk of anaphylactic reactions from contrast media used during cardiac catheterization is not increased in patients on beta-blockers or angiotensin-converting enzyme (ACE) inhibitors, according to results from a retrospective case-control study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 20, 2019 Category: Radiology Tags: Cardiology News Source Type: news

Kaiser unveils new cardiac cath lab in Moanalua Medical Center
Kaiser Permanente Hawaii saw its first patient at its new Cardiac Catheterization Lab at Moanalua Medical Center Tuesday. The $7.2 million project has been in the works for two years and offers the latest imaging technology, called Philips Azurion Biplane – a first in the Islands. "We're most excited about it to improve medical effectiveness for our members," said Andrew Giles, assistant hospital administrator at Moanalua Medical Center, in an interview with Pacific Business News. The lab includes… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 19, 2019 Category: Pharmaceuticals Authors: Kelsey Kukaua Source Type: news

Kaiser unveils new cardiac cath lab in Moanalua Medical Center
Kaiser Permanente Hawaii saw its first patient at its new Cardiac Catheterization Lab at Moanalua Medical Center Tuesday. The $7.2 million project has been in the works for two years and offers the latest imaging technology, called Philips Azurion Biplane – a first in the Islands. "We're most excited about it to improve medical effectiveness for our members," said Andrew Giles, assistant hospital administrator at Moanalua Medical Center, in an interview with Pacific Business News. The lab includes… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 19, 2019 Category: Biotechnology Authors: Kelsey Kukaua Source Type: news

Big Study Finds Many Heart Procedures Won ’t Cut Risk of Having Heart Attack
This study clearly goes against what has been the common wisdom for the last 30, 40 years” and may lead to less testing and invasive treatment for such patients in the future, said Dr. Glenn Levine, a Baylor College of Medicine cardiologist with no role in the research. Some doctors still may quibble with the study, but it was very well done “and I think the results are extremely believable,” he said. About 17 million Americans have clogged arteries that crimp the heart’s blood supply, which can cause periodic chest pain. Cheap and generic aspirin, cholesterol-lowering drugs and blood pressure medic...
Source: TIME: Health - November 16, 2019 Category: Consumer Health News Authors: ARILYNN MARCHIONE / AP Tags: Uncategorized onetime Research Source Type: news

Fasting Diet Could Benefit Heart Health: Study
SATURDAY, Nov. 16, 2019 -- Routine fasting may reduce the risk of heart failure and death in patients who have cardiac catheterization, a new study suggests. It included more than 2,000 patients who had cardiac catheterization between 2013 and 2015.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2019 Category: General Medicine Source Type: news

Intermittent fasting increases longevity in cardiac catheterization patients
(Intermountain Medical Center) In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don't. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 16, 2019 Category: International Medicine & Public Health Source Type: news

Shockwave Medical Eyes Japan as Next Market for IVL Device
Shockwave Medical is moving to get its Intravascular Lithotripsy (IVL) technology approved in Japan. The Santa Clara-based company said it has initiated the DISRUPT CAD IV study of IVL in heavily calcified coronary arteries. DISRUPT CAD IV is expected to enroll up to 64 patients at eight sites in Japan. Shockwave Medical pointed out the first CAD IV patient was enrolled earlier this week by the principal investigator of the study, Shigeru Saito, MD, Director of Cardiology and Catheterization Laboratories and Vice President, Shonan Kamakura General Hospital. The firm’s device is designed to fracture proble...
Source: MDDI - November 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

12 Innovations That Will Change Health Care and Medicine in the 2020s
Pocket-size ultrasound devices that cost 50 times less than the machines in hospitals (and connect to your phone). Virtual reality that speeds healing in rehab. Artificial intelligence that’s better than medical experts at spotting lung tumors. These are just some of the innovations now transforming medicine at a remarkable pace. No one can predict the future, but it can at least be glimpsed in the dozen inventions and concepts below. Like the people behind them, they stand at the vanguard of health care. Neither exhaustive nor exclusive, the list is, rather, representative of the recasting of public health and medic...
Source: TIME: Health - October 25, 2019 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized HealthSummit19 technology Source Type: news

Penumbra Looks to Bolster Indigo Through CHEETAH
The first patient has been enrolled in Penumbra’s CHEETAH post-market study to evaluate the Indigo System with CAT RX Aspiration Catheter in the coronary vessels. About 400 patients are expected to be enrolled at 25 centers in CHEETAH. Alameda, CA-based Penumbra’s Indigo System uses mechanical power aspiration to remove thrombus in the coronaries. The primary study endpoint is a composition of cardiovascular (CV) death, recurrent myocardial infarction (MI), cardiogenic shock or new or worsening New York Heart Association (NYHA) Class IV heart failure within 30 days. Secondary endpoints i...
Source: MDDI - October 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

MCI Linked to Lower Use of Cardiac Catheterization in AMI
Patients with preexisting MCI have lower use of cardiac catheterization, coronary revascularization (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 14, 2019 Category: Psychiatry Tags: Cardiology, Family Medicine, Internal Medicine, Neurology, Psychiatry, Surgery, Journal, Source Type: news

MCI Linked to Lower Use of Cardiac Catheterization in AMI
FRIDAY, Sept. 13, 2019 -- Preexisting mild cognitive impairment (MCI) is associated with a lower use of cardiac catheterization and coronary revascularization after acute myocardial infarction (AMI), according to a study published online Aug. 13 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2019 Category: Pharmaceuticals Source Type: news

How to Evaluate a Pediatric and Congenital Heart Surgery Program
Treatment TermsPediatric Heart SurgeryPediatric Heart TransplantPediatric Congenital Heart DefectsPediatric CardiologyPediatric Cardiac Intensive Care UnitPediatric Cardiac Catheterization Author Morgan deBlecourt Overview Congenital heart defects are present at birth. These structural defects may require surgery to fix. So how do you find the best care? Here ’s what you need to know when evaluating pediatric heart surgery programs and surgeons, and how Duke measures up. Content Blocks CTA ButtonPediatric Heart Surgery CTA Header Learn More About Hero Imageblog_evaluatepediatricheartprograms_1932x862.jpg Pr...
Source: dukehealth.org: Duke Health News - September 5, 2019 Category: Consumer Health News Authors: md141 at duke.edu Source Type: news

New heart and vascular tower expands cardiovascular, radiology services (video)
Atrium Health Cabarrus opened a new heart and vascular tower in August, increasing access to specialized care for patients across the region. The 163,000 square-foot building is part of a multi-year modernization project to transform the Cabarrus campus. The state-of-the-art facility houses Atrium Health’s Sanger Heart& Vascular Institute services and interventional radiology services, offering new cardiac catheterization labs, electrophysiology labs, pre-and-post op care services, and a cardiovascular … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 1, 2019 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

New heart and vascular tower expands cardiovascular, radiology services (video)
Atrium Health Cabarrus opened a new heart and vascular tower in August, increasing access to specialized care for patients across the region. The 163,000 square-foot building is part of a multi-year modernization project to transform the Cabarrus campus. The state-of-the-art facility houses Atrium Health’s Sanger Heart& Vascular Institute services and interventional radiology services, offering new cardiac catheterization labs, electrophysiology labs, pre-and-post op care services, and a cardiovascular … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 1, 2019 Category: Biotechnology Authors: Atrium Health Source Type: news

Philips asserts it has no intention of buying Corindus
Royal Philips said that it has no intention of acquiring robotic catheterization...Read more on AuntMinnie.comRelated Reading: Siemens to buy cardiac cath firm Corindus for $1.1B Philips, Carestream healthcare IT deal nears completion Philips reports continued sales growth in Q2 Philips highlights ambient room for FDG uptake Corindus taps new VP of global medical affairs Corindus lands new approval for CorPath (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 12, 2019 Category: Radiology Source Type: news

Siemens to buy cardiac cath firm Corindus for $1.1B
Siemens Healthineers has reached an agreement to buy robotic catheterization...Read more on AuntMinnie.comRelated Reading: SyntheticMR wins Siemens contract Siemens Healthineers posts Q3 revenue increases Siemens forms 10-year partnership with Mo. health network Siemens wins Canadian license for Mammomat Revelation Siemens launches remote coaching service for MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 9, 2019 Category: Radiology Source Type: news

PHOTOS: Efficiency key to Concord's new $115M heart and vascular tower
Atrium Health is set to open a $115.2 million heart and vascular tower to patients at its Concord hospital in mid-August. It's part of a larger modernization project at Atrium Health-Northeast. The 163,000-square-foot building will house Sanger Heart& Vascular Institute services, interventional radiology, cardiac catheterization, electrophysiology labs and a cardiac intensive care unit. Top of mind at this facility was efficiency, said Dr. Geoffrey Rose, chief of adult cardiology at Sanger Heart… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2019 Category: Pharmaceuticals Authors: Caroline Hudson Source Type: news

PHOTOS: Efficiency key to Atrium Health's new $115M heart and vascular tower
Atrium Health is set to open a $115.2 million heart and vascular tower to patients at its Concord hospital in mid-August. It's part of a larger modernization project at Atrium Health-Northeast. The 163,000-square-foot building will house Sanger Heart& Vascular Institute services, interventional radiology, cardiac catheterization, electrophysiology labs and a cardiac intensive care unit. Top of mind at this facility was efficiency, said Dr. Geoffrey Rose, chief of adult cardiology at Sanger Heart… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 26, 2019 Category: Biotechnology Authors: Caroline Hudson Source Type: news

PHOTOS: Efficiency key to Atrium Health's new $115M heart and vascular tower
Atrium Health is set to open a $115.2 million heart and vascular tower to patients at its Concord hospital in mid-August. It's part of a larger modernization project at Atrium Health-Northeast. The 163,000-square-foot building will house Sanger Heart& Vascular Institute services, interventional radiology, cardiac catheterization, electrophysiology labs and a cardiac intensive care unit. Top of mind at this facility was efficiency, said Dr. Geoffrey Rose, chief of adult cardiology at Sanger Heart… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 26, 2019 Category: Pharmaceuticals Authors: Caroline Hudson Source Type: news

Thin-Strut Bioresorbable Vascular Scaffold Shows Promise
A next-generation bioresorbable scaffold (BRS) system called MeRes 100, developed by Meril Life Sciences, is thinner than first-generation similar devices, with a low strut thickness of 100 microns. Two recent clinical studies have shown that this feature, along with some other innovations, have made it more successful than first-generation similar devices, and more important, safe and effective. First-generation devices were thick, took a long time to resorb, and easily fractured, according to ProfessorAlexandre Abizaid, chief of coronary interventions at Institute Dante Pazzanese de Cardiologia in Sao Paulo, Brazil, and ...
Source: MDDI - July 24, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Cardiovascular Source Type: news

Virginia Cardiologist Murdered While on Vacation in Belize Virginia Cardiologist Murdered While on Vacation in Belize
Gary Sw., MD, 53, was medical director of Carilion Clinic's Cardiac Catheterization Lab and an associate professor of internal medicine at the Virginia Tech Carilion School of Medicine in Roanoke.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Children's Hospital Colorado's Cardiac Catheterization Lab earns accreditation
(Children's Hospital Colorado) The Heart Institute at Children's Hospital Colorado has been granted the Intersocietal Accreditation Commission's (IAC) Cardiovascular Catheterization accreditation for Pediatric Cardiovascular Catheterization, Complex Adult Congenital Heart Disease, Valve Interventions, and Structural Heart Interventions. According to the IAC, this accreditation is a 'seal of approval' that patients can rely on as an indicator of consistent quality and a dedication to continuous improvement. This accreditation has so far only been achieved by three congenital cath labs in the US. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2019 Category: International Medicine & Public Health Source Type: news

New System Could Hold Promise for Patients Suffering from Pulmonary Arterial Hypertension
SoniVie’s recent clinical trial of TIVUS (therapeutic intravascular ultrasound) shows encouraging results for patients with pulmonary arterial hypertension (PAH). “The TROPHY1 study was our first human study in patients with pulmonary arterial hypertension,” said Charles Carignan, MD, CEO of SoniVie, in an interview with MD+DI. The results are from a 6-month follow-up for the 23 enrolled WHO Class 3 patients in the United States, Europe, and Israel. TIVUS is a catheter that goes either through the jugular vein or the femoral vein into the right side of the heart and pas...
Source: MDDI - June 5, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

Comic-style brochure may help surgical patients understand their procedure
A new comic-style brochure helped patients reduce stress by explaining cardiac catheterization, a procedure that inserts a stent to open a narrowed artery to increase blood flow. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 16, 2019 Category: Consumer Health News Source Type: news

Operator-Directed Sedation Seems Safe in Peds Cardiac Cath
FRIDAY, April 12, 2019 -- For carefully selected pediatric patients, operator-directed sedation (ODS) for congenital cardiac catheterization procedures is not associated with an increased risk for adverse events and may reduce case time and charges,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2019 Category: Pharmaceuticals Source Type: news

Minnesota Resuscitation Consortium Advanced Perfusion & Reperfusion Cardiac Life Support Strategy for Out-of-Hospital Refractory V Fib
Approximately 400,000 people in the United States suffer out-of-hospital cardiac arrest (OHCA) each year. One-third present to EMS with a shockable rhythm (v fib/v tach). Of these patients with an initial shockable rhythm, 50% are refractory to treatment resulting in prolonged duration of resuscitation and poor outcomes.1,2 The Minnesota Resuscitation Consortium (MRC) initiated the Advanced Perfusion and Reperfusion Cardiac Life Support Strategy for Out-of-Hospital Refractory Ventricular Fibrillation (v fib) in December 2015, in an effort to improve survival outcomes for patients suffering refractory v fib arrest. Extracor...
Source: JEMS Patient Care - February 27, 2019 Category: Emergency Medicine Authors: Jason Bartos, MD, PhD Tags: Cardiac & Resuscitation Top Story Exclusive Articles Patient Care Heart of America Source Type: news

Here ’ s how a new Abbott device is making a difference among neonatal infants
[Image courtesy of Abbott]A recent CBS News report provided a real-life example of how Abbott’s Piccolo occluder is making a difference among neonatal infants with a congenital heart defect called patent ductus arteriosus (PDA). Irie and Judah Felkner are now healthy, growing 18-month-olds. But when Irie was born early at just 1 pound 13 ounces, she had a life-threatening PDA that left her mom Crissa Felkner scared that they weren’t going to bring her home. “We saw that Irie’s heart was enlarging in size and more and more fluid was collecting in her lungs,” Dr. Aimee Armstr...
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Cardiovascular Catheters Featured News Well Abbott Source Type: news

Teleflex wins FDA PMA for Manta large bore vascular closure device
Teleflex (NYSE:TFX) said today that it won FDA premarket approval for its Manta vascular closure device, touting it as the first such device specifically designed for large bore femoral access site closures. The newly cleared Manta device won indications for closing femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths in endovascular catheterization procedures, the Wayne, Penn.-based company said. “Our team has been working hard to obtain FDA premarket approval and were confident they would recognize the benefits that the Manta Device can provide to the p...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Featured Food & Drug Administration (FDA) Pre-Market Approval (PMA) Regulatory/Compliance Vascular Teleflex Source Type: news

Girls ’ Pain Taken Less Seriously Than Boys ’ , Study Finds
By Ryan Prior, CNN (CNN) — Our long-held notions of boys as being more stoic and girls as being more expressive may lead Americans to overrate the severity of male physical pain. A recent study by psychologists at Yale University found that adults, when presented with imagery of a child’s finger being pricked, considered the child to be in less pain when they thought it was a girl. The study, published in The Journal of Pediatric Psychology, involved showing 264 adult participants a video of a child whose gender appeared ambiguous. Afterwards one group of participants was told the child in the video was named S...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 1, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Cardiac Surgery Not Linked to Cognitive Decline Cardiac Surgery Not Linked to Cognitive Decline
Previous research has suggested high rates of cognitive decline following cardiac surgery, but a new study finds no such association with surgery vs cardiac catheterization.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 28, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Cardiovascular Systems touts first patients treated with Teleport microcatheter
Cardiovascular Systems (NSDQ:CSII) touted today that the first patients in the U.S. were treated with the OrbusNeich Teleport microcatheter. The device, which recently won 510(k) clearance with the FDA, enables safe guidewire exchange during cardiovascular procedures. The Teleport product features a robust tip to provide access to challenging lesions, according to Cardiovascular Systems. Dr. Annapoorna Kini, director of the Cardiac Catheterization Lab at Mount Sinai Medical Center and Dr. Emmanouil Brilakis of the Minneapolis Heart Institute treated the first U.S. patients with Teleport. “I am excited and honore...
Source: Mass Device - December 26, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Cardiovascular Catheters Featured Wall Street Beat Cardiovascular Systems Inc. OrbusNeich Source Type: news

Cognitive Decline Similar After Cardiac Surgery, Catheterization
TUESDAY, Dec. 18, 2018 -- For older adults, declines in memory after heart surgery and cardiac catheterization are similar, according to a study published online Dec. 18 in the Annals of Thoracic Surgery. Elizabeth L. Whitlock, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2018 Category: Pharmaceuticals Source Type: news

Upper Valley Medical Center makes another investment
Upper Valley Medical Center, the largest employer in Miami County, continues to invest in its local operations. Most recently, the center expanded the capabilities at its cardiac catheterization lab. As such, individuals experiencing a heart attack and those with non-emergency coronary blockages will benefit from more treatment options. With more capabilities and availability of additional experienced cardiologists, patients who need angioplasty and many types of stents will be able to receive them… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 17, 2018 Category: American Health Authors: Caleb Stephens Source Type: news

Corindus touts first-in-human coronary telerobotics study with CorPath system
Corindus Vascular Robotics (OTC:CVRS) today touted that its CorPath robotic surgical platform was used in a first-in-human telerobotic intervention study in India. The Waltham, Mass.-based company touted that the study was the world’s first percutaneous coronary intervention conducted from a remote location outside of a catheterization lab. In the trial, five patients at India’s Apex Heart Institute underwent an elective PCI procedure from a distance of approximately 20 miles away, Corindus said. The procedures were performed by Apex Heart Institute chair and chief interventional cardiologist Dr. Tejas Pat...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Featured Robotics Corindus Vascular Robotics Source Type: news

ECG Educational Standards for Prehospital Providers
Conclusion As the role of evidence-based medicine becomes more prominent in the field of emergency medicine, a clear view of the current state of ECG education and platform from which to implement uniform standards becomes increasingly essential; especially as research expands into the prehospital setting. Further research into EMS education may identify both strengths and weaknesses in basic ECG interpretation appropriate for first responders. Implementing minimum ECG interpretation standards for EMS personnel nationwide is one potential option to ensure prehospital educational institutions stay responsive to current scie...
Source: JEMS Special Topics - November 28, 2018 Category: Emergency Medicine Authors: Jonathan Barney, BA, EMT, MS3 Tags: Training Exclusive Articles Cardiac & Resuscitation Source Type: news

Major Bleeding Up With Frailty in Acute MI Patients
TUESDAY, Nov. 20, 2018 -- Frail acute myocardial infarction (AMI) patients are less likely to undergo cardiac catheterization and have an increased risk for bleeding, according to a study published in the Nov. 26 issue of JACC: Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2018 Category: Pharmaceuticals Source Type: news

Gates Vascular Institute okayed for 'revolutionary' stroke upgrade
Buffalo General Medical Center has received state approvals to add 4-D imaging equipment adjacent to its emergency department, a move it says will “revolutionize” stroke treatment. The hospital filed plans this summer to invest $2.5 million in a 4-Dimensional Computed Tomography system from Canon Medical USA, creating a cardiac catheterization lab suite within Buff Gen’s Gates Vascular Institute emergency department. The state Departme nt of Health approved the project Oct. 10.  The equipment… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 15, 2018 Category: American Health Authors: Tracey Drury Source Type: news

FDA clears Transseptal Solutions ’ TP Crosser transseptal access device
Medtech developer Transseptal Solutions said yesterday it won FDA 510(k) clearance for its TSP Crosser transseptal access system. The Israel-based company said that the TSP Crosser is an advanced transseptal puncture system which features a built-in steering mechanism and is designed for use in accessing the left atrium. The system is intended for use during procedures including mitral valve repair and replacement, paravalvular leak closure, left atrial appendage closure and EP ablation treatments. “Transseptal Solutions FDA clearance announcement is timely. There is a growing global demand for trans-septal catheter ...
Source: Mass Device - October 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance transseptalsolutions Source Type: news

Dartmouth Institute receives $3.5 million for research to prevent acute kidney injury
(The Dartmouth Institute for Health Policy& Clinical Practice) Acute kidney injury (AKI) occurs in up to 14 percent of all patients following a cardiac catheterization and up to 50 percent in patients with pre-existing kidney disease. A research team led by Dartmouth Institute Associate Professor Jeremiah Brown, PhD, MS, recently was awarded a $3.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to test preventative interventions through a virtual learning collaborative with or without automated surveillance reporting (ASR). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Teleflex picks up Essential Medical and its Manta vascular closure device
Teleflex (NYSE:TFX) said yesterday that it acquired Essential Medical and its Manta vascular closure device for an unspecified amount. Manta is designed to close punctures at femoral arterial access sites after catheterization procedures, including transcatheter aortic valve replacements, endovascular treatment of abdominal aortic aneurysms, ventricular assist procedures and balloon aortic valvuloplasties. Exton, Pa.-based Essential won CE Mark approval in the European Union for Manta in July 2016 and is seeking pre-market approval from the FDA. The federal safety watchdog granted an investiga...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Mergers & Acquisitions Vascular Wall Street Beat Essential Medical Devices Teleflex Source Type: news

Are You Tall? Better Watch Out For Varicose Veins
(CNN) — In what researchers are calling “the largest genetic study ever performed” on varicose vein disease, a Stanford University School of Medicine study found a person’s height to be a significant risk factor for developing varicose veins. “We not only found an association between height and varicose veins, but the genetic studies we did showed a causal link,” said cardiologist and study author Dr. Nicholas Leeper, an associate professor of surgery and cardiovascular medicine at Stanford. “That suggests that the genes and pathways that drive human height are also likely to be ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Varicose Veins Source Type: news

Notifying cath labs early improves treatment speed, outcome
Informing cardiac catheterization labs of incoming heart attack patients 10...Read more on AuntMinnie.comRelated Reading: Ultrasound contrast can help treat heart attacks Trial: Catheter device cuts contrast use Automated coronary plaque analysis predicts future events Use criteria cut unnecessary heart interventions PROSPECT: IVUS improves PCI outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2018 Category: Radiology Source Type: news

The role of cardiac catheterization after cardiac arrest
(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 137-148(12); DOI. Ahmed Harhash, Prashant Rao, and Karl B. Kern from the University of Arizona Sarver Heart Center, Tucson, Ariz., USA consider the role of cardiac catheterization after cardiac arrest. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2018 Category: International Medicine & Public Health Source Type: news

Transporting Patients to Appropriate Receiving Destinations
Conclusion EMS is in a position to be the initiator of specialty center destination. In large cities with multiple hospitals, EMS should transport patients to the closest, most appropriate facility based on patient condition, even if this requires passing a closer facility. Where there are hospitals with multiple specialty services, EMS may be asked to activate a specific team, such as the stroke or cardiac team. In rural communities, EMS can communicate with the local hospital and by letting the hospital know of patient condition, help start the interfacility transport process from the field....
Source: JEMS Special Topics - July 19, 2018 Category: Emergency Medicine Authors: Dennis Edgerly, MEd, EMT-P Tags: Exclusive Articles Columns Operations Source Type: news

Urinary monitor dev Potrero Medical closes $27m Series C
Predictive health company Potrero Medical said yesterday it closed a $26.6 million Series C funding to help support commercialization of its flagship Accuryn monitoring system. The San Francisco-based company’s Accuryn system is designed to use urinary catheters as diagnostic tools. The device provides real-time measurements of intra-abdominal pressure, urine output and core body temperature and can be integrated into hospital EMR systems, the company said. Financing in the round was led by GT Healthcare Capital Partners and Sonder Capital, Potrero Medical said. “We are excited to be a part of Potrero Medi...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Urology Potrero Medical Source Type: news

' Extended Reality' Comes to the Cath Lab'Extended Reality' Comes to the Cath Lab
From virtual dissections to real-time 3D hologram-assisted cardiac catheterization,'extended reality'technologies are set to affect cardiovascular medicine in the very near future.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Where are the Low-Hanging Fruits for Device Manufacturers?
(Part One of a Two-Part Series) As the U.S. healthcare system becomes increasingly value-oriented, a relatively new phenomenon is occurring—the increased use of risk-sharing arrangements between manufacturers and providers or payers, where payments for devices are tied to patient outcomes and/or financial metrics. In early 2018, leading medical-device manufacturer Medtronic announced it had a risk-sharing arrangement in place with more than 1,000 hospitals for its TYRX technology for cardiac implants in the U.S., an increase of about 700 hospitals over six months. Medtronic has also started five other simil...
Source: MDDI - April 2, 2018 Category: Medical Devices Authors: Harry Liu and Christine Chen Tags: Business Source Type: news